Search Results 1541-1550 of 19429 for hemoglobin

  1. 64Cu-SAR-bisPSMA And 67Cu-SAR-bisPSMA For Identification And Treatment Of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) - Mayo Clinic

    Hemoglobin ≥9 g/dL (5.59 mmol/L);. Total bilirubin ≤1.5 x the institutional upper limit of normal (ULN). For participants with known Gilbert's Syndrome ≤3 ...

  2. Neurosurgery - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  3. Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL; Platelets ≥ 100,000/mcL; Total bilirubin ≤ 1.5x the upper limit of normal (ULN); Serum glutamic pyruvic transaminase (SGPT) (alanine ...

  4. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

    Serum or plasma hemoglobin; Ann Arbor stage Additionally, patients must have beta-2-microglobulin collected at time of registration. Females of childbearing ...

  5. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Hemoglobin (Hgb) ≥ 9 g/dl; Platelet count (PLT) ≥ 100,000/uL; Serum bilirubin within normal range (or ≤ 1.5 x upper limit of normal [ULN] if liver ...

  6. A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers - Mayo Clinic

    Participation eligibility · Hemoglobin ≥ 8 g/dL; · Absolute neutrophil count ≥ 1000/μL; · Platelet count ≥ 75,000/μL (≥ 30,000/μL if bone marrow plasma cells ...

  7. Neurology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  8. A Study of TAS-120 in Patients with Advanced Solid Tumors - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL;; Phosphorus ≤ ULN. Creatinine clearance (calculated* or measured value**): ≥ 40 mL/min. * For a calculated creatinine clearance (Ccr) ...

  9. Mayo Clinic Minute: Research shows newer blood thinners have lower risk of kidney function decline

    People with A-fib often have problems with blood clots forming that can lead to strokes. To prevent the clots, health care providers generally prescribe these ...

  10. A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433 - Mayo Clinic

    Hemoglobin < 8 g/dL. Enrollment in another interventional clinical study while participating in this study. For Substudy 3 only: Total SES-CD > 4 and/or ...